The immunogenicity comparisons FDA wants to see are "really important data to decide if and when to pull the trigger on a variant vaccine," Georgetown's Jesse Goodman says. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
